Results of a double-blind placebo-controlled study of the double-stranded RNA drug polyI:PolyC12U in the treatment of HIV infection

This publication has 21 references indexed in Scilit:

• Polyinosinic acid: polycytidylic acid promotes T helper type 1‐specific immune responses by stimulating macrophage production of interferon‐α and interleukin‐12
  European Journal of Immunology, 1995
• Delayed-Type Hypersensitivity Skin Tests Are an Independent Predictor of Human Immunodeficiency Virus Disease Progression
  The Journal of Infectious Diseases, 1994
• Mode of Action of the Anti-AIDS Compound Poly(I)·Poly(C₁₂U) (Ampligen): Activator of 2′,5′-Oligoadenylate Synthetase and Double-Stranded RNA-Dependent Kinase
  Journal of Interferon Research, 1993
• A TH1→TH2 switch is a critical step in the etiology of HIV infection
  Immunology Today, 1993
• The effect of combinations of ampligen and zidovudine or dideoxyinosine against human immunodeficiency viruses in vitro
  Antiviral Research, 1992
• Antiviral Action of Polyadenylic-Polyuridylic Acid Against HIV in Cell Cultures
  AIDS Research and Human Retroviruses, 1992
• Free and Liposome-Encapsulated Double-Stranded RNAs as Inducers of Interferon, Interleukin-6, and Cellular Toxicity
  Journal of Interferon Research, 1991
• Mismatched double-stranded RNA, ampligen (poly(I) : poly(C12U)), demonstrates antiviral and immunostimulatory activities in HIV disease
  International Journal of Immunopharmacology, 1991
• In Vitro Evaluation of Mismatched Double-Stranded RNA (Ampligen) for Combination Therapy in the Treatment of Acquired Immunodeficiency Syndrome
  AIDS Research and Human Retroviruses, 1989
• Structural requirements of the rIn·rCn complex for Induction of human interferon
  Journal of Molecular Biology, 1972